Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Insulin Resistance in Mild Cognitive Impairment

NCT06116188 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT06116188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06116188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Insulin Resistance in Mild Cognitive Impairment
Lead sponsor
Turku University Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 12, 2023
Completion date
October 10, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment, positron emission tomography